Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.
about
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)Xa inhibitors for acute coronary syndromesAcute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarctionNadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study designArterial indications for the low molecular weight heparinsHigh-sensitivity cardiac troponin testing in routine practice: economic and organizational advantagesGuidelines for acute coronary syndromes: translating the evidence to best practiceClinical implications of CURE and PCI-CURE in patients with the acute coronary syndrome without persistent ST-elevationGap between guidelines and management of patients with acute coronary syndrome without persistent ST elevation. Finnish prospective follow-up surveyImpact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registryDiagnosis and treatment of acute myocardial infarction in tertiary and secondary care hospitals in EstoniaClopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarctionPercutaneous coronary intervention: recommendations for good practice and training.The incidence of myocardial injury following post-operative Goal Directed TherapyClinical application of enoxaparin.Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.Do inter-hospital comparisons of in-hospital, acute myocardial infarction case-fatality rates serve the purpose of fostering quality improvement? An evaluative study.Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.Review of enoxaparin and its clinical applications in venous and arterial thromboembolism.Perioperative myocardial infarction in noncardiac surgery: the diagnostic and prognostic role of cardiac troponins.Evaluation in an emergency department of rapid separator tubes containing thrombin for serum preparation prior to hs-cTnT and CK-MB analysesAssociations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.Critical review of unstable angina and non-ST elevation myocardial infarctionPotential nontraditional applications of statins.The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosisAre district general hospital patients with unstable angina at a disadvantage?Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarctionMulticentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practiceRecognising and treating the diabetic patient in cardiovascular care.The role of low-molecular-weight heparins in cardiovascular medicine.An exploratory mixed methods analysis of adherence predictors following acute coronary syndrome.Effect of atorvastatin therapy on borderline vulnerable lesions in patients with acute coronary syndrome.Silent myocardial ischaemia: clinical relevance and treatment.Troponin: think before you request oneUsing the 12-lead ECG to assess acute coronary patients.Allelic polymorphism in the promoter (T-->C), but not in exon 7 (G-->T) or the variable number tandem repeat in intron 4, of the endothelial nitric oxide synthase gene is positively associated with acute coronary syndrome in the Ukrainian populationNon ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.Biomarkers of cardiovascular damage.Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study.Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study.
P2860
Q22242088-AD1757F2-A14F-4BD1-B870-D8AF0EC3BFB8Q24243766-4C9F655B-7FAD-490E-B4D2-641C22551070Q24527255-E9160F8A-3772-49B7-AEC6-651B058AE992Q24794480-B7C773F7-B8BE-476A-9984-A7B050A0DAE6Q24806932-1A8FA0A3-4C88-4AB3-947B-99343B14E0A9Q26738522-EB8F5325-C735-4B41-A7E2-B93CA0B69B1DQ28187314-7CA14195-5B5E-4B11-A2B7-EBCDD620625BQ28194398-78503F22-20E9-46E6-917A-B521AEB7065EQ28209040-311E88A0-5F30-483E-882C-52EC41EECE00Q28217870-D76007C6-B0BE-40FC-8308-20972E4E0AB4Q28218781-FCC5862C-7C00-4C58-802F-60DAB2216A26Q28222524-2BE2AECE-D0EE-44DB-9235-BC5601F6D50DQ30479477-366C0EC2-684C-4C98-8593-5F4FCD274CCBQ33279362-92E58DE3-6F72-440F-8500-E3D71938253AQ33360866-E95BBFFE-C23B-4C89-B29A-89D4AF988748Q33360869-DFA8874C-BBD9-4B21-830F-C6EDCE6228DEQ33766878-E6A01C1E-7DCC-4AC5-B8DF-A966A8075F90Q34189648-386D107F-66DA-4FE0-B5EA-5C61CE470E3BQ34628623-AEDE2CE3-5983-4B0F-ADFB-F1DBA65F3E9DQ34696254-7CD57C3D-85FF-429F-9465-C2868F34F5D4Q34771430-DE906C7C-7C1C-4562-AF54-B55108C0C202Q34974622-0FC57A5C-D642-4A09-92FC-84F8F39963C8Q35037630-28F42386-011F-425D-B09F-4B47E20E8F6AQ35169445-8A55DE44-14B0-4DDA-BB72-278C628CF629Q35297209-ED9083FE-5C98-4895-B871-429941F8B57FQ35516108-839F0FDC-87EE-4B27-9316-0C29D8F33A32Q35580412-7874F2E7-6BC1-4DF4-940B-F17C80886B3FQ35580971-34B6B7C4-39AA-4F66-BE3D-4C6F974BD683Q35586294-D66835CB-71C8-425C-B281-3C8C7E6E77C4Q35591215-A2FFF26A-5BD0-4F6F-A867-D096110BEB20Q35591550-DF8AF13B-AE4A-4538-BBB4-226B3D635A17Q35674176-BD8524AD-46B9-401C-A322-7D485FD27852Q36120776-1227B7D4-35E7-4AE5-9BED-3BB8A398C672Q36282559-D8D006CB-50DF-4814-8A8A-4F79ACD6A8F1Q36395370-99F9845B-1460-44A9-B770-8D3AEC402212Q36508410-43918788-DC86-478A-BA74-C54CA65AEBACQ36519924-BC6B498C-8535-4328-8C78-3B75CCD35C50Q36836546-1C971E8C-FFE9-44B9-BACD-834508C33F71Q37100870-FFC9FC0B-CE5A-4A89-A7A3-55E95BBF6E0CQ37175783-1EA91A68-5038-4674-8B1A-1482CCEB9009
P2860
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Management of acute coronary s ...... uropean Society of Cardiology.
@ast
Management of acute coronary s ...... uropean Society of Cardiology.
@en
Management of acute coronary s ...... uropean Society of Cardiology.
@nl
type
label
Management of acute coronary s ...... uropean Society of Cardiology.
@ast
Management of acute coronary s ...... uropean Society of Cardiology.
@en
Management of acute coronary s ...... uropean Society of Cardiology.
@nl
prefLabel
Management of acute coronary s ...... uropean Society of Cardiology.
@ast
Management of acute coronary s ...... uropean Society of Cardiology.
@en
Management of acute coronary s ...... uropean Society of Cardiology.
@nl
P2093
P356
P1476
Management of acute coronary s ...... European Society of Cardiology
@en
P2093
Bertrand ME
McFadden E
Simoons ML
Specchia G
Wallentin LC
de Feyter PJ
P304
P356
10.1053/EUHJ.2000.2301
P577
2000-09-01T00:00:00Z